source
- Medrio aims to unify clinical trial tools to ease complexity for biotech firmsMike Novotny, founder and CEO of Medrio, says that funding cycles, growing study complexity and fragmented technology are slowing clinical research, especially for small and midsize life‑science co…
- AbbVie reports Phase 3 success for lutikizumab in painful skin disease, eyes FDA filing next yearAbbVie announced positive Phase 3 trial results for its experimental IL-1α and IL-1β inhibitor lutikizumab, which is being developed to treat a debilitating skin condition. The study reported impr…